VMPLNew Delhi [India], May 2: In a significant step up from a largely domestic industrial player to a contender in the global oil and gas supply chain, Atam Valves Limited has secured the American ...

Telegram trading bots have become a core part of the crypto workflow for many traders, and that is easy to understand once you spend a little time with them. Inside Telegram, they combine alerts, ...

Manhattan Associates Inc. (NASDAQ: MANH) and Genuine Parts Company (GPC) have announced the successful go-live of Manhattan ...

This session will explore how AI-driven API testing enables teams to handle massive test volumes, complex business logic, and continuous delivery demands at scale.

This April, Changelly, an instant cryptocurrency exchange platform trusted by millions of users and over 600 partners, launched Changelly DeFi, a cross-chain swap service for individual users and a ...

Hackers gained access to an API for the CPUID project and changed the download links on the official website to serve malicious executables for the popular CPU-Z and HWMonitor tools. The two utilities ...

Burger King is testing a new lineup of slider-sized burgers in two U.S. cities, as the thriving fast-food chain continues to refresh its menu and attract customers seeking more variety and flexible ...

The King is getting into the slider game. Burger King announced in an April 8 news release that it will test a new "King Size Sliders Box" in two cities for a limited time. "From sharing with friends ...

SAN FRANCISCO, April 8, 2026 /PRNewswire/ -- KushoAI, an AI-native platform for API testing and software reliability, has introduced APIEval-20, an open benchmark designed to evaluate how effectively ...

Bangladesh's pharmaceutical industry is often described as one of the country's most significant industrial achievements. In the decades following independence, Bangladesh moved from near-total ...

A federal inquiry into the financial and national security implications of pharmaceutical imports is leading President Trump to impose steep new fees, but they won’t touch the medicines that most ...